The Changing Landscape of Anticoagulation in Pediatric Extracorporeal Membrane Oxygenation: Use of the Direct Thrombin Inhibitors

Bleeding and thrombosis frequently occur in pediatric patients with extracorporeal membrane oxygenation (ECMO) therapy. Until now, most patients are anticoagulated with unfractionated heparin (UFH). However, heparin has many disadvantages, such as binding to other plasma proteins and endothelial cel...

Descripción completa

Detalles Bibliográficos
Autores principales: Neunert, Cindy, Chitlur, Meera, van Ommen, Cornelia Heleen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299072/
https://www.ncbi.nlm.nih.gov/pubmed/35872781
http://dx.doi.org/10.3389/fmed.2022.887199

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299072/
https://www.ncbi.nlm.nih.gov/pubmed/35872781
http://dx.doi.org/10.3389/fmed.2022.887199

Ejemplares similares